Skip to main content
Top
Gepubliceerd in:

06-10-2022 | Review

Patient-reported cognitive function among hematopoietic stem cell transplant and cellular therapy patients: a scoping review

Auteurs: Rachel Cusatis, Joanna Balza, Zachary Uttke, Vishwajit Kode, Elizabeth Suelzer, Bronwen E. Shaw, Kathryn E. Flynn

Gepubliceerd in: Quality of Life Research | Uitgave 4/2023

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Cognitive dysfunction is a known complication following cellular therapies (CT), which can be assessed through performance based and patient-reported measures. We performed a systematic scoping review to assess self-reported cognitive function measures used among adult CT patients and describe long-term results, including associations with clinical outcomes.

Methods

Library databases were searched from inception to February 2020 according to PRISMA guidelines. Additional studies were identified through reference lists and trial protocols. Two members of the research team screened titles and abstracts and resolved discrepancies. Articles that met eligibility criteria continued to full-text review, with 25% double screening. Articles were removed if they (1) were not original research, peer-reviewed articles; (2) were the wrong disease, age, or treatment-specific patient population; (3) did not use patient-reported outcomes; (4) did not separately report cognitive function outcomes.

Results

Of the1952 articles, 56 were included. Twenty-one patient-reported measures of cognitive function were used; most frequently the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30), which includes a two-item cognitive function subscale (57%; n = 32). Thirteen studies collected performance-based and self-reported measures and of those (n = 6) who assessed associations found moderate correlations (range r = .13-.58). Longitudinal patterns showed declines in cognitive function soon after treatment (< 1 month) returning to baseline at 1 year. Cognitive function was often associated with other quality of life measures, chiefly depression (n = 5).

Conclusions

EORTC-QLQ-C30 is the most commonly used to measure, though there remain numerous measures used, including several measures with little previous validation and investigator developed items.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Dietrich, J., Monje, M., Wefel, J., Meyers, C., & Pappas, C. (2008). Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. The Oncologist, 13, 1285–1295.PubMedCrossRef Dietrich, J., Monje, M., Wefel, J., Meyers, C., & Pappas, C. (2008). Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. The Oncologist, 13, 1285–1295.PubMedCrossRef
2.
go back to reference Lee, D. W., et al. (2019). ASTCT Consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biology of Blood and Marrow Transplantation, 25, 625–638.PubMedCrossRef Lee, D. W., et al. (2019). ASTCT Consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biology of Blood and Marrow Transplantation, 25, 625–638.PubMedCrossRef
4.
go back to reference Buchbinder, D., et al. (2018). 2018 Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplantation, 535(53), 535–555.CrossRef Buchbinder, D., et al. (2018). 2018 Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplantation, 535(53), 535–555.CrossRef
5.
go back to reference Food, U. S., Administration, D., & Others. (2009). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Federal Register, 74, 65132–65133. Food, U. S., Administration, D., & Others. (2009). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Federal Register, 74, 65132–65133.
6.
go back to reference Kamal, M., et al. (2021). Patient-reported outcomes for cancer patients with hematological malignancies undergoing chimeric antigen receptor t cell therapy: A systematic review. Transplantation Cellular Therapy., 27(390), e1-390.e7. Kamal, M., et al. (2021). Patient-reported outcomes for cancer patients with hematological malignancies undergoing chimeric antigen receptor t cell therapy: A systematic review. Transplantation Cellular Therapy., 27(390), e1-390.e7.
7.
go back to reference Maziarz, R. T., et al. (2020). Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma. Blood Advances, 4, 629–637.PubMedPubMedCentralCrossRef Maziarz, R. T., et al. (2020). Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma. Blood Advances, 4, 629–637.PubMedPubMedCentralCrossRef
9.
go back to reference Hutchinson, A. D., Hosking, J. R., Kichenadasse, G., Mattiske, J. K., & Wilson, C. (2012). Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews, 38, 926–934.PubMedCrossRef Hutchinson, A. D., Hosking, J. R., Kichenadasse, G., Mattiske, J. K., & Wilson, C. (2012). Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews, 38, 926–934.PubMedCrossRef
10.
go back to reference Saffer, B. Y., Lanting, S. C., Koehle, M. S., Klonsky, E. D., & Iverson, G. L. (2015). Assessing cognitive impairment using PROMIS® applied cognition-abilities scales in a medical outpatient sample. Psychiatry Research, 226, 169–172.PubMedCrossRef Saffer, B. Y., Lanting, S. C., Koehle, M. S., Klonsky, E. D., & Iverson, G. L. (2015). Assessing cognitive impairment using PROMIS® applied cognition-abilities scales in a medical outpatient sample. Psychiatry Research, 226, 169–172.PubMedCrossRef
11.
go back to reference Iverson, G. L., Marsh, J. M., Connors, E. J., & Terry, D. P. (2021). Normative reference values, reliability, and item-level symptom endorsement for the PROMIS® v2.0 cognitive function-short forms 4a, 6a and 8a. Archives Clinical Neuropsychology, 36, 1341–1349.CrossRef Iverson, G. L., Marsh, J. M., Connors, E. J., & Terry, D. P. (2021). Normative reference values, reliability, and item-level symptom endorsement for the PROMIS® v2.0 cognitive function-short forms 4a, 6a and 8a. Archives Clinical Neuropsychology, 36, 1341–1349.CrossRef
12.
go back to reference Lai, J.-S., Wagner, L. I., Jacobsen, P. B., & Cella, D. (2014). Self-reported cognitive concerns and abilities: Two sides of one coin? Psycho-Oncology, 23, 1133–1141.PubMedPubMedCentralCrossRef Lai, J.-S., Wagner, L. I., Jacobsen, P. B., & Cella, D. (2014). Self-reported cognitive concerns and abilities: Two sides of one coin? Psycho-Oncology, 23, 1133–1141.PubMedPubMedCentralCrossRef
14.
go back to reference Garcia, S. F., et al. (2007). Standardizing patient-reported outcomes assessment in cancer clinical trials: A patient-reported outcomes measurement information system initiative. Journal of Clinical Oncology, 25, 5106–5112.PubMedCrossRef Garcia, S. F., et al. (2007). Standardizing patient-reported outcomes assessment in cancer clinical trials: A patient-reported outcomes measurement information system initiative. Journal of Clinical Oncology, 25, 5106–5112.PubMedCrossRef
15.
go back to reference Henneghan, A. M., et al. (2021). Measuring Self-reported cancer-related cognitive impairment: recommendations from the cancer neuroscience initiative working group. JNCI J Natl Cancer Inst, 113, 1625.PubMedCrossRef Henneghan, A. M., et al. (2021). Measuring Self-reported cancer-related cognitive impairment: recommendations from the cancer neuroscience initiative working group. JNCI J Natl Cancer Inst, 113, 1625.PubMedCrossRef
16.
go back to reference Tricco, A. C., et al. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169, 467–473.PubMedCrossRef Tricco, A. C., et al. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169, 467–473.PubMedCrossRef
17.
go back to reference A, E. et al. Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews. in Abstracts of the 22nd Cochrane Colloquium 9 (John Wiley & Sons, 2014). A, E. et al. Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews. in Abstracts of the 22nd Cochrane Colloquium 9 (John Wiley & Sons, 2014).
18.
go back to reference Correa, D. D., et al. (2019). Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation. Journal of Neuro-oncology, 144, 553–562.PubMedPubMedCentralCrossRef Correa, D. D., et al. (2019). Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation. Journal of Neuro-oncology, 144, 553–562.PubMedPubMedCentralCrossRef
19.
go back to reference Fann, J. R., Roth-Roemer, S., Burington, B. E., Katon, W. J., & Syrjala, K. L. (2002). Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer, 95, 1971–1981.PubMedCrossRef Fann, J. R., Roth-Roemer, S., Burington, B. E., Katon, W. J., & Syrjala, K. L. (2002). Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer, 95, 1971–1981.PubMedCrossRef
20.
go back to reference Dean, H. F., et al. (2012). Defects in lymphocyte subsets and serological memory persist a median of 10 years after high-dose therapy and autologous progenitor cell rescue for malignant lymphoma. Bone Marrow Transplantation, 47, 1545–1551.PubMedCrossRef Dean, H. F., et al. (2012). Defects in lymphocyte subsets and serological memory persist a median of 10 years after high-dose therapy and autologous progenitor cell rescue for malignant lymphoma. Bone Marrow Transplantation, 47, 1545–1551.PubMedCrossRef
21.
go back to reference Deeg, H. J., et al. (1998). Long-term outcome after marrow transplantation for severe aplastic anemia. Blood, 91, 3637–3645.PubMedCrossRef Deeg, H. J., et al. (1998). Long-term outcome after marrow transplantation for severe aplastic anemia. Blood, 91, 3637–3645.PubMedCrossRef
22.
go back to reference Andrykowski, M. A., Henslee, P. J., & Barnett, R. L. (1989). Longitudinal assessment of psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplantation, 4, 505–509.PubMed Andrykowski, M. A., Henslee, P. J., & Barnett, R. L. (1989). Longitudinal assessment of psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplantation, 4, 505–509.PubMed
24.
go back to reference Bush, N. E., Donaldson, G. W., Haberman, M. H., Dacanay, R., & Sullivan, K. M. (2000). Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: A longitudinal follow-up of 415 patients. Biology of Blood and Marrow Transplantation, 6, 576–591.PubMedCrossRef Bush, N. E., Donaldson, G. W., Haberman, M. H., Dacanay, R., & Sullivan, K. M. (2000). Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: A longitudinal follow-up of 415 patients. Biology of Blood and Marrow Transplantation, 6, 576–591.PubMedCrossRef
25.
go back to reference Alaloul, F., Brockopp, D. Y., Andrykowski, M. A., Hall, L. A., & Al Nusairat, T. S. (2015). Quality of life in Arab Muslim cancer survivors following hematopoietic stem cell transplantation: Comparison with matched healthy group. Supportive Care in Cancer, 23, 2157–2164.PubMedCrossRef Alaloul, F., Brockopp, D. Y., Andrykowski, M. A., Hall, L. A., & Al Nusairat, T. S. (2015). Quality of life in Arab Muslim cancer survivors following hematopoietic stem cell transplantation: Comparison with matched healthy group. Supportive Care in Cancer, 23, 2157–2164.PubMedCrossRef
26.
go back to reference Schoulte, J. C., Lohnberg, J. A., Tallman, B., & Altmaier, E. M. (2011). Influence of coping style on symptom interference among adult recipients of hematopoietic stem cell transplantation. Oncology Nursing Forum, 38(5), 582–586.PubMedCrossRef Schoulte, J. C., Lohnberg, J. A., Tallman, B., & Altmaier, E. M. (2011). Influence of coping style on symptom interference among adult recipients of hematopoietic stem cell transplantation. Oncology Nursing Forum, 38(5), 582–586.PubMedCrossRef
27.
go back to reference Acaster, S., Gaugris, S., Velikova, G., Yong, K., & Lloyd, A. J. (2013). Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: A UK cross-sectional survey. Supportive Care in Cancer, 21, 599–607.PubMedCrossRef Acaster, S., Gaugris, S., Velikova, G., Yong, K., & Lloyd, A. J. (2013). Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: A UK cross-sectional survey. Supportive Care in Cancer, 21, 599–607.PubMedCrossRef
28.
go back to reference Harder, H., et al. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer, 95, 183–192.PubMedCrossRef Harder, H., et al. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer, 95, 183–192.PubMedCrossRef
29.
go back to reference Schulz-Kindermann, F., et al. (2007). Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies. Bone Marrow Transplantation, 3912(39), 789–799.CrossRef Schulz-Kindermann, F., et al. (2007). Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies. Bone Marrow Transplantation, 3912(39), 789–799.CrossRef
30.
go back to reference Booth-Jones, M., Jacobsen, P. B., Ransom, S., & Soety, E. (2005). Characteristics and correlates of cognitive functioning following bone marrow transplantation. Bone Marrow Transplantation, 368(36), 695–702.CrossRef Booth-Jones, M., Jacobsen, P. B., Ransom, S., & Soety, E. (2005). Characteristics and correlates of cognitive functioning following bone marrow transplantation. Bone Marrow Transplantation, 368(36), 695–702.CrossRef
31.
go back to reference Sanders, J. E., et al. (2010). The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplantation, 454(45), 746–754.CrossRef Sanders, J. E., et al. (2010). The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplantation, 454(45), 746–754.CrossRef
32.
go back to reference Bishop, M. M., et al. (2007). Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. Journal of Clinical Oncology, 25, 1403–1411.PubMedCrossRef Bishop, M. M., et al. (2007). Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. Journal of Clinical Oncology, 25, 1403–1411.PubMedCrossRef
33.
go back to reference Caocci, G., et al. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Bone Marrow Transplantation, 17, 3637–3645. Caocci, G., et al. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Bone Marrow Transplantation, 17, 3637–3645.
34.
go back to reference Jarden, M., Nelausen, K., Hovgaard, D., Boesen, E., & Adamsen, L. (2009). The effect of a multimodal intervention on treatment-related symptoms in patients undergoing hematopoietic stem cell transplantation: A randomized controlled trial. Journal of Pain and Symptom Management, 38, 174–190.PubMedCrossRef Jarden, M., Nelausen, K., Hovgaard, D., Boesen, E., & Adamsen, L. (2009). The effect of a multimodal intervention on treatment-related symptoms in patients undergoing hematopoietic stem cell transplantation: A randomized controlled trial. Journal of Pain and Symptom Management, 38, 174–190.PubMedCrossRef
35.
go back to reference Ahmedzai, S. H., et al. (2019). Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma. Journal of Clinical Oncology, 37, 1617.PubMedPubMedCentralCrossRef Ahmedzai, S. H., et al. (2019). Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma. Journal of Clinical Oncology, 37, 1617.PubMedPubMedCentralCrossRef
36.
go back to reference Mayo, S., et al. (2016). Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation. Bone Marrow Transplantation, 516(51), 841–847.CrossRef Mayo, S., et al. (2016). Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation. Bone Marrow Transplantation, 516(51), 841–847.CrossRef
37.
go back to reference El-Banna, M. M., et al. (2004). Fatigue and depression in patients with lymphoma undergoing autologous peripheral blood stem cell transplantation. Oncology Nursing Forum, 31, 937–944.PubMedCrossRef El-Banna, M. M., et al. (2004). Fatigue and depression in patients with lymphoma undergoing autologous peripheral blood stem cell transplantation. Oncology Nursing Forum, 31, 937–944.PubMedCrossRef
38.
go back to reference Watson, M., et al. (2004). Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: Analysis of the UK Medical Research Council AML 10 Trial. European Journal of Cancer, 40, 971–978.PubMedCrossRef Watson, M., et al. (2004). Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: Analysis of the UK Medical Research Council AML 10 Trial. European Journal of Cancer, 40, 971–978.PubMedCrossRef
39.
go back to reference Wu, L. M., et al. (2012). Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant. Psycho-Oncology, 21, 1175–1184.PubMedCrossRef Wu, L. M., et al. (2012). Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant. Psycho-Oncology, 21, 1175–1184.PubMedCrossRef
40.
go back to reference Jacobs, S. R., Jacobsen, P. B., Booth-Jones, M., Wagner, L. I., & Anasetti, C. (2007). Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoetic stem cell transplant patients. Journal of Pain and Symptom Management, 33, 13–23.PubMedCrossRef Jacobs, S. R., Jacobsen, P. B., Booth-Jones, M., Wagner, L. I., & Anasetti, C. (2007). Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoetic stem cell transplant patients. Journal of Pain and Symptom Management, 33, 13–23.PubMedCrossRef
41.
go back to reference Andrykowski, M. A., et al. (1990). Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: Relationship to dose of total body irradiation. Bone Marrow Transplantation, 6, 269–276.PubMed Andrykowski, M. A., et al. (1990). Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: Relationship to dose of total body irradiation. Bone Marrow Transplantation, 6, 269–276.PubMed
42.
go back to reference Sarkar, S., et al. (2014). Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT. Bone Marrow Transplantation, 499(49), 1217–1222.CrossRef Sarkar, S., et al. (2014). Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT. Bone Marrow Transplantation, 499(49), 1217–1222.CrossRef
43.
go back to reference Ghazikhanian, S. E., et al. (2017). Cognitive problems following hematopoietic stem cell transplant: Relationships with sleep, depression and fatigue. Bone Marrow Transplantation, 522(52), 279–284.CrossRef Ghazikhanian, S. E., et al. (2017). Cognitive problems following hematopoietic stem cell transplant: Relationships with sleep, depression and fatigue. Bone Marrow Transplantation, 522(52), 279–284.CrossRef
44.
go back to reference Harder, H., et al. (2007). Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: Two-year follow-up results. European Journal of Cancer, 43, 2052–2059.PubMedCrossRef Harder, H., et al. (2007). Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: Two-year follow-up results. European Journal of Cancer, 43, 2052–2059.PubMedCrossRef
45.
go back to reference Larsen, J., Nordström, G., Ljungman, P., & Gardulf, A. (2007). Factors associated with poor general health after stem-cell transplantation. Supportive Care in Cancer, 15, 849–857.PubMedCrossRef Larsen, J., Nordström, G., Ljungman, P., & Gardulf, A. (2007). Factors associated with poor general health after stem-cell transplantation. Supportive Care in Cancer, 15, 849–857.PubMedCrossRef
46.
go back to reference Baker, F., Denniston, M., Zabora, J. R., & Marcellus, D. (2003). Cancer problems in living and quality of life after bone marrow transplantation. Journal of Clinical Psychology Medical Settings, 101(10), 27–34.CrossRef Baker, F., Denniston, M., Zabora, J. R., & Marcellus, D. (2003). Cancer problems in living and quality of life after bone marrow transplantation. Journal of Clinical Psychology Medical Settings, 101(10), 27–34.CrossRef
47.
go back to reference Molassiotis, A., Wilson, B., Blair, S., Howe, T., & Cavet, J. (2011). Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psycho-Oncology, 20, 88–97.PubMedCrossRef Molassiotis, A., Wilson, B., Blair, S., Howe, T., & Cavet, J. (2011). Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psycho-Oncology, 20, 88–97.PubMedCrossRef
48.
go back to reference Stewart, A. K., et al. (2013). A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: The National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial. Blood, 121, 1517–1523.PubMedPubMedCentralCrossRef Stewart, A. K., et al. (2013). A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: The National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial. Blood, 121, 1517–1523.PubMedPubMedCentralCrossRef
49.
go back to reference Clavert, A., et al. (2017). Late complications and quality of life after reduced-intensity conditioning allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 23, 140–146.PubMedCrossRef Clavert, A., et al. (2017). Late complications and quality of life after reduced-intensity conditioning allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 23, 140–146.PubMedCrossRef
50.
go back to reference Velikova, G., et al. (2007). The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. European Journal of Cancer, 43, 87–94.PubMedCrossRef Velikova, G., et al. (2007). The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. European Journal of Cancer, 43, 87–94.PubMedCrossRef
51.
go back to reference Jim, H. S. L., et al. (2012). Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation. Cancer, 118, 3407–3416.PubMedCrossRef Jim, H. S. L., et al. (2012). Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation. Cancer, 118, 3407–3416.PubMedCrossRef
52.
go back to reference Gruters, A. A. A., et al. (2019). Association between proxy- or self-reported cognitive decline and cognitive performance in memory clinic visitors. Journal of Alzheimer’s Disease, 70, 1225–1239.PubMedCrossRef Gruters, A. A. A., et al. (2019). Association between proxy- or self-reported cognitive decline and cognitive performance in memory clinic visitors. Journal of Alzheimer’s Disease, 70, 1225–1239.PubMedCrossRef
53.
go back to reference Howland, M., et al. (2017). Patient-rated versus proxy-rated cognitive and functional measures in older adults. Patient Related Outcome Measures, 8, 33.PubMedPubMedCentralCrossRef Howland, M., et al. (2017). Patient-rated versus proxy-rated cognitive and functional measures in older adults. Patient Related Outcome Measures, 8, 33.PubMedPubMedCentralCrossRef
54.
go back to reference Sidana, S., et al. (2019). Patient experience of chimeric antigen receptor (CAR)-T cell Therapy vs. stem cell transplant: Longitudinal patient reported adverse events, cognition and quality of life. Blood, 134, 794.CrossRef Sidana, S., et al. (2019). Patient experience of chimeric antigen receptor (CAR)-T cell Therapy vs. stem cell transplant: Longitudinal patient reported adverse events, cognition and quality of life. Blood, 134, 794.CrossRef
55.
go back to reference Chakraborty, R., et al. (2019). Patient-reported outcomes with chimeric antigen receptor T Cell therapy: challenges and opportunities. Biology of Blood and Marrow Transplantation, 25, e155–e162.PubMedCrossRef Chakraborty, R., et al. (2019). Patient-reported outcomes with chimeric antigen receptor T Cell therapy: challenges and opportunities. Biology of Blood and Marrow Transplantation, 25, e155–e162.PubMedCrossRef
56.
go back to reference Andresen, S., et al. (2012). The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma. Leukaemia & Lymphoma, 53, 386–393.CrossRef Andresen, S., et al. (2012). The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma. Leukaemia & Lymphoma, 53, 386–393.CrossRef
57.
go back to reference Bartley, E. J., et al. (2014). Holding back moderates the association between health symptoms and social well-being in patients undergoing hematopoietic stem cell transplantation. Journal of Pain and Symptom Management, 48, 374–384.PubMedCrossRef Bartley, E. J., et al. (2014). Holding back moderates the association between health symptoms and social well-being in patients undergoing hematopoietic stem cell transplantation. Journal of Pain and Symptom Management, 48, 374–384.PubMedCrossRef
58.
go back to reference Basinski, J. R., Alfano, C. M., Katon, W. J., Syrjala, K. L., & Fann, J. R. (2010). Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant. Biology of Blood and Marrow Transplantation, 16, 824–831.PubMedPubMedCentralCrossRef Basinski, J. R., Alfano, C. M., Katon, W. J., Syrjala, K. L., & Fann, J. R. (2010). Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant. Biology of Blood and Marrow Transplantation, 16, 824–831.PubMedPubMedCentralCrossRef
59.
go back to reference Bonifazi, F., et al. (2019). GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: Final results of quality of life and long-term outcome analysis of a phase 3 randomised study. Lancet Haematol, 6, e89–e99.PubMedCrossRef Bonifazi, F., et al. (2019). GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: Final results of quality of life and long-term outcome analysis of a phase 3 randomised study. Lancet Haematol, 6, e89–e99.PubMedCrossRef
60.
go back to reference Braamse, A. M. J., et al. (2014). Distress, problems and supportive care needs of patients treated with auto- or allo-SCT. Bone Marrow Transplantation, 492(49), 292–298.CrossRef Braamse, A. M. J., et al. (2014). Distress, problems and supportive care needs of patients treated with auto- or allo-SCT. Bone Marrow Transplantation, 492(49), 292–298.CrossRef
61.
go back to reference Caocci, G., et al. (2006). Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: Quality of life, communication and ethical issues. Bone Marrow Transplantation, 372(37), 165–169.CrossRef Caocci, G., et al. (2006). Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: Quality of life, communication and ethical issues. Bone Marrow Transplantation, 372(37), 165–169.CrossRef
62.
go back to reference Chang, G., Meadows, M. E., Orav, E. J., & Antin, J. H. (2009). Mental status changes after hematopoietic stem cell transplantation. Cancer, 115, 4625–4635.PubMedCrossRef Chang, G., Meadows, M. E., Orav, E. J., & Antin, J. H. (2009). Mental status changes after hematopoietic stem cell transplantation. Cancer, 115, 4625–4635.PubMedCrossRef
64.
go back to reference Crooks, M., Seropian, S., Bai, M., & McCorkle, R. (2014). Monitoring patient distress and related problems before and after hematopoietic stem cell transplantation. Palliative & Supportive Care, 12, 53–61.CrossRef Crooks, M., Seropian, S., Bai, M., & McCorkle, R. (2014). Monitoring patient distress and related problems before and after hematopoietic stem cell transplantation. Palliative & Supportive Care, 12, 53–61.CrossRef
65.
go back to reference Hacker, E. D., et al. (2006). Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncology Nursing Forum, 33, 614–624.CrossRef Hacker, E. D., et al. (2006). Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncology Nursing Forum, 33, 614–624.CrossRef
66.
go back to reference Epstein, J. B., et al. (2002). Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation, 3011(30), 785–792.CrossRef Epstein, J. B., et al. (2002). Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation, 3011(30), 785–792.CrossRef
67.
go back to reference Ghazikhanian, S. E., et al. (2016). Cognitive problems following hematopoietic stem cell transplant: Relationships with sleep, depression and fatigue. Bone Marrow Transplantation, 52, 279–284.PubMedPubMedCentralCrossRef Ghazikhanian, S. E., et al. (2016). Cognitive problems following hematopoietic stem cell transplant: Relationships with sleep, depression and fatigue. Bone Marrow Transplantation, 52, 279–284.PubMedPubMedCentralCrossRef
68.
go back to reference Harder, H., et al. (2005). Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: A comparative study. European Journal of Cancer, 41, 1007–1016.PubMedCrossRef Harder, H., et al. (2005). Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: A comparative study. European Journal of Cancer, 41, 1007–1016.PubMedCrossRef
69.
go back to reference Hayden, P. J., et al. (2004). A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase. Bone Marrow Transplantation, 346(34), 545–556.CrossRef Hayden, P. J., et al. (2004). A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase. Bone Marrow Transplantation, 346(34), 545–556.CrossRef
70.
go back to reference Hendriks, M. G. J., & Schouten, H. C. (2002). Quality of life after stem cell transplantation: A patient, partner and physician perspective. European Journal of Internal Medicine, 13, 52–56.PubMedCrossRef Hendriks, M. G. J., & Schouten, H. C. (2002). Quality of life after stem cell transplantation: A patient, partner and physician perspective. European Journal of Internal Medicine, 13, 52–56.PubMedCrossRef
71.
go back to reference Hjermstad, M. J., Holte, H., Evensen, S. A., Fayers, P. M., & Kaasa, S. (1999). Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year? Bone Marrow Transplantation, 24, 911–918.PubMedCrossRef Hjermstad, M. J., Holte, H., Evensen, S. A., Fayers, P. M., & Kaasa, S. (1999). Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year? Bone Marrow Transplantation, 24, 911–918.PubMedCrossRef
72.
go back to reference Hjermstad, M. J., Evensen, S. A., Kvaløy, S. O., Fayers, P. M., & Kaasa, S. (1999). Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: A prospective study. Journal of Clinical Oncology, 17, 706–718.PubMedCrossRef Hjermstad, M. J., Evensen, S. A., Kvaløy, S. O., Fayers, P. M., & Kaasa, S. (1999). Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: A prospective study. Journal of Clinical Oncology, 17, 706–718.PubMedCrossRef
73.
go back to reference Hong, F., Bosco, J. L. F., Bush, N., & Berry, D. L. (2013). Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy. BMC Cancer, 13, 1–8.CrossRef Hong, F., Bosco, J. L. F., Bush, N., & Berry, D. L. (2013). Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy. BMC Cancer, 13, 1–8.CrossRef
74.
go back to reference Hung, Y. C., et al. (2014). Telephone-delivered nutrition and exercise counselling after auto-SCT: A pilot, randomised controlled trial. Bone Marrow Transplantation, 496(49), 786–792.CrossRef Hung, Y. C., et al. (2014). Telephone-delivered nutrition and exercise counselling after auto-SCT: A pilot, randomised controlled trial. Bone Marrow Transplantation, 496(49), 786–792.CrossRef
75.
go back to reference Jones, D., et al. (2013). Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer, 119, 4188–4195.PubMedCrossRef Jones, D., et al. (2013). Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer, 119, 4188–4195.PubMedCrossRef
76.
go back to reference Kav, S., et al. (2009). Quality of life and difficulties of patients encountered after autologous stem cell transplantation. Journal of BUON, 14, 673–680.PubMed Kav, S., et al. (2009). Quality of life and difficulties of patients encountered after autologous stem cell transplantation. Journal of BUON, 14, 673–680.PubMed
77.
go back to reference Naegele, M., et al. (2018). Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: A descriptive longitudinal study. Supportive Care in Cancer, 26, 833–841.PubMedCrossRef Naegele, M., et al. (2018). Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: A descriptive longitudinal study. Supportive Care in Cancer, 26, 833–841.PubMedCrossRef
78.
go back to reference Persoon, S., et al. (2017). Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study. PLoS ONE, 12, e0181313.PubMedPubMedCentralCrossRef Persoon, S., et al. (2017). Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study. PLoS ONE, 12, e0181313.PubMedPubMedCentralCrossRef
79.
go back to reference Wu, L. M., et al. (2014). Cross-sectional study of patient-reported neurobehavioral problems following hematopoietic stem cell transplant and health-related quality of life. Psycho-Oncology, 23, 1406–1414.PubMedCrossRef Wu, L. M., et al. (2014). Cross-sectional study of patient-reported neurobehavioral problems following hematopoietic stem cell transplant and health-related quality of life. Psycho-Oncology, 23, 1406–1414.PubMedCrossRef
80.
go back to reference Wu, L. M., et al. (2019). A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors. Palliative & Supportive Care, 17, 396.CrossRef Wu, L. M., et al. (2019). A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors. Palliative & Supportive Care, 17, 396.CrossRef
Metagegevens
Titel
Patient-reported cognitive function among hematopoietic stem cell transplant and cellular therapy patients: a scoping review
Auteurs
Rachel Cusatis
Joanna Balza
Zachary Uttke
Vishwajit Kode
Elizabeth Suelzer
Bronwen E. Shaw
Kathryn E. Flynn
Publicatiedatum
06-10-2022
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 4/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-022-03258-0

Andere artikelen Uitgave 4/2023

Quality of Life Research 4/2023 Naar de uitgave